"Designing Growth Strategies is in our DNA"

U.S. Regenerative Medicine Market Size, Share, Analysis, By Product (Cell Therapy, Gene Therapy, Tissue Engineering, and Platelet Rich Plasma), By Application (Orthopedics, Wound Care, Oncology, Rare Diseases, and Others), By End User (Hospitals, Clinics, and Others), and Country Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI108493

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Chronic Diseases in the U.S., 2022/2023
    2. Pipeline Analysis, By Key Players
    3. New Product Launches, By Key Players
    4. Key Industry Developments: Mergers, Acquisitions & Partnerships
    5. Technological Advancement in Regenerative Medicine
    6. Impact of COVID-19 on the Market
  5. U.S. Regenerative Medicine Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Cell Therapy
      2. Gene Therapy
      3. Tissue Engineering
      4. Platelet Rich Plasma
    2. Market Analysis, Insights and Forecast – By Application
      1. Orthopedics
      2. Wound Care
      3. Oncology
      4. Rare Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinics
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Integra LifeSciences Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Bristol-Myers Squibb Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Tissue Regenix
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Smith & Nephew
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. MiMedx
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Allergan Aesthetics (AbbVie Inc.)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Stryker
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. American CryoStem Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Kite (Gilead Sciences, Inc.)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      11. AlloSource
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      12. bluebird bio, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      13. CRISPR Therapeutics
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      14. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      15. Tegoscience
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1:  U.S. Regenerative Medicine Market Revenue Breakdown (USD billion, %), by Region, By Product, 2024 & 2032

Figure 2:  U.S. Regenerative Medicine Market Value Share (%), by Product, 2024 & 2032

Figure 3:  U.S. Regenerative Medicine Market Value Share (%), By Application, 2024 & 2032

Figure 4:  U.S. Regenerative Medicine Market Value Share (%), By End User, 2024 & 2032

Figure 5:  U.S. Regenerative Medicine Market Share Analysis, 2023

Table 1:  U.S. Regenerative Medicine Market Revenue (USD billion) Forecast, By Product, 2019-2032

Table 2: U.S. Regenerative Medicine Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 3: U.S. Regenerative Medicine Market Revenue (USD billion) Forecast, By End User, 2019-2032

U.S. Regenerative Medicine Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 70
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase